Ballast Asset Management’s iRadimed IRMD Stock Holding History

Ballast Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.57M	Buy	37,107 +870	+2%	+$87K	1.59%	34
2025 Q4	$3.53M	Sell	36,237 -1,218	-3%	-$104K	1.67%	33
2025 Q3	$2.67M	Sell	37,455 -3,459	-8%	-$230K	1.22%	41
2025 Q2	$2.45M	Hold	40,914	–	–	1.27%	37
2025 Q1	$2.15M	Buy	40,914 +594	+1%	+$33.4K	1.13%	42
2024 Q4	$2.22M	Sell	40,320 -1,388	-3%	-$73K	1.1%	41
2024 Q3	$2.1M	Sell	41,708 -592	-1%	-$27.3K	1.07%	45
2024 Q2	$1.86M	Buy	42,300 +2,548	+6%	+$108K	1.01%	46
2024 Q1	$1.75M	Buy	39,752 +3,528	+10%	+$156K	0.95%	45
2023 Q4	$1.72M	Buy	36,224 +11,136	+44%	+$468K	1.09%	45
2023 Q3	$1.11M	Buy	+25,088	New	+$1.17M	1.03%	43

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ballast Asset Management's IRMD Position: Q1 2026 in Review

Ballast Asset Management increased its iRadimed (IRMD) stake by 2.4% in Q1 2026, buying an estimated $87K and bringing the position to 37,107 shares worth $3.57M. The position accounts for 1.59% of the portfolio, ranked #34.

Ballast Asset Management first reported a position in IRMD in Q3 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

Ballast Asset Management held 37,107 shares of iRadimed worth $3.57M as of Q1 2026.
Ballast Asset Management bought 870 iRadimed shares in Q1 2026, an estimated $87K.
iRadimed made up 1.59% of Ballast Asset Management's portfolio in Q1 2026, its #34 holding.
Ballast Asset Management first reported a position in iRadimed in Q3 2023 and has held it in 11 quarters since.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Ballast Asset Management's 13F filing for Q1 2026, filed 7 May 2026.